|
|
|
|
|
by orra
1687 days ago
|
|
That it's unethical to continue giving half the participants a placebo makes sense. I am curious though: do they ever continue with the trial, with the patients on the actual drug? Might that be useful for monitoring rare-ish side effects, even if the drug is highly effective? |
|